Enhanced efficacy of human brain-derived neural stem cells by transplantation of cell aggregates in a rat model of parkinson’s disease

Journal of Korean Neurosurgical Society

Volumn 56, Issue 5, 2014, Pages 383-389

  Shin, Eun Sil ^a   Hwang, Onyou ^a   Hwang, Yu Shik ^b   Suh, Jun Kyo Francis ^c   Chun, Young Il ^d   Jeon, Sang Ryong ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

Author keywords

Cell aggregates; Cell transplantation; Human brain derived neural stem cells; Parkinson s disease; Rat model; 18F FP CIT microPET

Indexed keywords

BETA 2 MICROGLOBULIN; CYCLOSPORIN A; DOPAMINE TRANSPORTER; FLUORODEOXYGLUCOSE F 18; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL AGGREGATION; CELL COUNTING; CELL DENSITY; CELL SURVIVAL; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; DYSKINESIA; EXPERIMENTAL BEHAVIORAL TEST; FEMALE; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRE-CLINICAL IMAGING DEVICE; RAT;

EID: 84919415123     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2014.56.5.383     Document Type: Article

References (30)

1. Agid Y: Parkinson’s disease: pathophysiology. Lancet 337: 1321-1324, 1991
2. Björklund A, Dunnett SB, Stenevi U, Lewis ME, Iversen SD: Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res 199: 307-333, 1980
3. Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, et al.: Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 34: 1583-1593, 2007
4. Dauer W, Przedborski S: Parkinson’s disease: mechanisms and models. Neuron 39: 889-909, 2003
5. Dawson TM, Dawson VL: Molecular pathways of neurodegeneration in Parkinson’s disease. Science 302: 819-822, 2003
6. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI: Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 55: 138-142, 1992
7. Downes JH, Hammond MW, Xydas D, Spencer MC, Becerra VM, Warwick K, et al.: Emergence of a small-world functional network in cultured neurons. PLoS Comput Biol 8: e1002522, 2012
8. Erdö F, Bührle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, et al.: Host- dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 23: 780-785, 2003
9. Hagell P, Piccini P, Björklund A, Brundin P, Rehncrona S, Widner H, et al.: Dyskinesias following neural transplantation in Parkinson’s disease. Nat Neurosci 5: 627-628, 2002
10. Hedlund E, Perlmann T: Neuronal cell replacement in Parkinson’s disease. J Intern Med 266: 358-371, 2009
11. Hwang O, Baker H, Gross S, Joh TH: Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells. Synapse 28: 140-153, 1998
12. Bjorklund A, Dunnett SB, Brundin P, Stoessl AJ, Freed CR, Breeze RE, et al.: Neural transplantation for the treatment of Parkinson’s disease. Lancet Neurol 2: 437-445, 2003
13. Kato-Negishi M, Tsuda Y, Onoe H, Takeuchi S: A neurospheroid network-stamping method for neural transplantation to the brain. Biomaterials 31: 8939-8945, 2010
14. Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, et al.: Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med 39: 1521-1530, 1998
15. Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, et al.: Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 101: 11839-11844, 2004
16. Kim JS, Lee JS, Im KC, Kim SJ, Kim SY, Lee DS, et al.: Performance measurement of the microPET focus 120 scanner. J Nucl Med 48: 1527-1535, 2007
17. Kim ST, Choi JH, Chang JW, Kim SW, Hwang O: Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J Neurochem 95: 89-98, 2005
18. Lei Z, Jiang Y, Li T, Zhu J, Zeng S: Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease. J Neuropathol Exp Neurol 70: 736-747, 2011
19. Lund RD, Hauschka SD: Transplanted neural tissue develops connections with host rat brain. Science 193: 582-584, 1976
20. McNaught KS, Belizaire R, Jenner P, Olanow CW, Isacson O: Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson’s disease. Neurosci Lett 326: 155-158, 2002
21. Mehta V, Spears J, Mendez I: Neural transplantation in Parkinson’s disease. Can J Neurol Sci 24: 292-301, 1997
22. Nikkhah G, Cunningham MG, Cenci MA, McKay RD, Björklund A: Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J Neurosci 15 (5 Pt 1): 3548-3561, 1995
23. Olanow CW, Kordower JH, Freeman TB: Fetal nigral transplantation as a therapy for Parkinson’s disease. Trends Neurosci 19: 102-109, 1996
24. Paillé V, Henry V, Lescaudron L, Brachet P, Damier P: Rat model of Parkinson’s disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias. Mov Disord 22: 533-539, 2007
25. Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, et al.: Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Neuroscience 95: 377-388, 2000
26. Rehncrona S: A critical review of the current status and possible developments in brain transplantation. Adv Tech Stand Neurosurg 23: 3-46, 1997
27. Tabbal S, Fahn S, Frucht S: Fetal tissue transplantation [correction of transplanation] in Parkinson’s disease. Curr Opin Neurol 11: 341-349, 1998
28. Williams LN, Seignourel P, Crucian GP, Okun MS, Rodriguez RL, Skidmore FM, et al.: Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson’s disease. Mov Disord 22: 141-145, 2007
29. Yoon HH, Lee CS, Hong SH, Min J, Kim YH, Hwang O, et al.: Evaluation of a multiple system atrophy model in rats using multitracer microPET. Acta Neurochir (Wien) 154: 935-940, 2012
30. Yoon HH, Min J, Shin N, Kim YH, Kim JM, Hwang YS, et al.: Are human dental papilla-derived stem cell and human brain-derived neural stem cell transplantations suitable for treatment of Parkinson’s disease? Neural Regen Res 8: 1190-1200, 2013